Effect of VIA-2291 on Vascular Inflammation after ACS

ID Number 07-1060

Principal Investigator(s)
Michael E Farkouh

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of this study is to determine the effect of VIA-2291 as compared to placebo on vascular inflammation following 24 weeks of dosing. ClinicalTrials.gov Identifier: NCT00552188

Contact Information
Kshitij Shah
(212) 659-8847

Recruiting Patients: No